Whether the epidemiological association of amyloid beta (Aβ) and tau pathology with Alzheimer's disease (AD) is causal remains unclear. The recent failures to demonstrate the efficacy of several amyloid beta-modifying drugs may indicate the possibility that the observed association is not causal. These failures also led to efforts to develop tau-directed treatments whose efficacy is still tentative. Herein, we conducted a two-sample Mendelian randomization analysis to determine whether the relationship between the cerebrospinal fluid (CSF) biomarkers for amyloid and tau pathology and the risk of AD is causal. We used the summary statistics of a genome-wide association study (GWAS) for CSF biomarkers (Aβ 1-42 , phosphorylated tau 181 [p-tau], and total tau [t-tau]) in 3,146 individuals and for late-onset AD (LOAD) in 21,982 LOAD cases and 41,944 cognitively normal controls. We tested the association between the change in the genetically predicted CSF biomarkers and LOAD risk.
Introduction
pleiotropic variants among the exposure-associated variants 30 . Considering the SNPs that had a direct effect on LOAD, which means a direct pleiotropic effect on the outcome of interest, we excluded rs769449 in the apolipoprotein E (APOE) region that is highly associated with LOAD from the set of IVs 31, 32 . The APOE region has been reported to have multiple pleiotropic effects in many previous studies 33 . When the MR analysis is performed with the outliers detected by MR-PRESSO or variants in the APOE region, including the pleiotropic SNPs in the instruments, it may result in a positive bias or a negative bias due to horizontal pleiotropy and induce inaccurate causal relationship 34 . Therefore, we excluded the outliers detected by MR-PRESSO. Subsequently, to confirm the absence of horizontal pleiotropy, we performed the MR-Egger intercept test with the intercept unconstrained 35 . The intercept of the MR-Egger regression represents a statistical estimate of the directional pleiotropic effect, which can be a confounding factor in MR. The selected genetic variants are listed in Supplementary Tables 1-3 .
Two-sample Mendelian randomization method
TSMR utilizes the GWAS summary statistics obtained from two large sample sets, allowing to use more robustly associated genetic instruments compared with one-sample MR 17 . TSMR in the present study was performed using the Two Sample MR R package (version 0.4.22) from the MR-Base platform 29 . To confirm that the findings of the estimation of the causal effect of the exposures on the risk of LOAD are credible, we used diverse methods, including the inverse-variance weighted (IVW), maximum likelihood, weighted median, and MR-Egger regression. These multiple methods have been developed and differ from each other in terms of sensitivity to heterogeneity, bias, and power. We selected the IVW method as our primary MR method because it provides reliable results in the presence of heterogeneity in an MR analysis and is appropriate when using a large number of SNPs 36 . The standard error (SE) of the IVW effect was estimated using a multiplicative random effects model. We performed a leave-one-out analysis that estimates the causal effect of all but one SNP at a time iteratively, using the IVW method, to test if the results were derived from any particular SNP.
The maximum likelihood method is a likelihood-based method that assumes a bivariate normal distribution of the exposure and outcome, which better elucidates the correlation between two different GWAS summary statistics than does the IVW 23 . We also used the weighted median and MR-Egger regression. Since these two methods provide convincing causal estimates in the presence of violation of the MR assumptions, they were used as sensitivity analyses in the MR studies 35, 37 .
We used a forest plot to visualize the heterogeneity between the instruments due to horizontal pleiotropy and the contribution of each instrument to the overall estimate 29 . A funnel plot showing the proportion of the precision (1/ SE) to Wald ratios per SNP was used to evaluate the bias due to the invalid instruments. The overall symmetry in the funnel plot represents the lack of severe heterogeneity and bias driven by directional horizontal pleiotropy that violates the MR assumptions 38 .
Power calculation
We calculated the statistical power of the MR using an online tool (https://sb452.shinyapps.io/power/) 39 based on the proportion of variance in the exposure (R 2 ) explained by genetic instruments, true causal effect of the exposure on the outcome, sample size, and ratio of cases to controls of the outcome. R 2 was obtained from the MR-Steiger directionality test 40 . We estimated the true causal effect based on the observed odds ratios (ORs) between the CSF biomarkers and the risk of LOAD.
Results
In our main analysis, we excluded the outliers using MR-PRESSO to select suitable instruments that satisfied one of the core IV assumptions, that is, no horizontal pleiotropy.
The number of the outlier SNPs predicted to have pleiotropy by MR-PRESSO was one (out of 15 top SNPs) and thirteen (out of 20 top SNPs) for CSF Aβ and p-tau, respectively. After excluding the outliers, the MR-Egger intercept test showed no evidence of horizontal pleiotropy in both Aβ and p-tau (Aβ: intercept = -0.027, SE = 0.015, P = 1; p-tau: intercept = -0.004, SE = 0.044, P = 0.93) ( Supplementary Table 4 ).
CSF Aβ showed evidence for a causal effect on the risk for LOAD (IVW OR, 0.63 for LOAD per 1 standard deviation (SD) increase in the genetically predicted CSF Aβ; 95% confidence interval [CI], 0.38-0.87; P = 0.02) ( Table 1 and Fig. 1A) . We found a more prominent causality between CSF p-tau and the risk for LOAD (IVW OR, 2.37 for LOAD per 1 SD increase in the genetically predicted CSF p-tau; 95% CI, 1.46-3.28; P = 1.09×10 -5 ) ( Table 1 and Fig. 1C ). In the sensitivity analyses, the causal effect of CSF p-tau on the risk for LOAD was significant in both the maximum likelihood and the weighted median (maximum likelihood P = 2.98×10 -5 and weighted median P = 2.51×10 -4 ), while the causal association between CSF Aβ and the risk for LOAD was significant in the maximum likelihood (P = 0.03). Both CSF Aβ and CSF p-tau were not significant in the MR-Egger regression. Although the effect estimate for CSF p-tau was similar to that derived by the IVW, maximum likelihood, and weighted median, the estimates for CSF Aβ were different. MR-Egger was shown to yield minimally biased estimates regardless of the pleiotropic SNPs in the instruments 35 . However, in our MR analysis, the potential pleiotropic SNPs were detected as outliers using the MR-PRESSO and all of them were excluded, which may suggest that the IVW has a greater power and derives a more precise estimate than the MR-Egger regression.
While the effect size for CSF Aβ on the risk for LOAD yielded patterns indicating a moderate heterogeneity among the instruments, the instruments of CSF p-tau showed little heterogeneity ( Fig. 1B and Fig. 1D ). The Cochran Q statistics, P value, and heterogeneity (I 2 [%]) were 13.41, 0.42, and 3 for CSF Aβ, and 1.58, 0.95, and 0 for CSF p-tau, respectively (Supplementary Tables 4) . The leave-one-out analysis confirmed that a single SNP was not exclusively responsible for the associations with the risk for LOAD ( Fig. 2A and Fig. 2C ). In the funnel plot, each dot shows the proportion of the precision (1/SE) to Wald ratio per SNP and the vertical lines represent the MR estimates jointed by the instruments (Fig. 2B and Fig.   2D ). We observed an overall symmetry in the funnel plot, which indicates that our results were less likely biased by invalid instruments.
We also investigated the association between t-tau and the risk for LOAD. In contrast to CSF p-tau, no causal evidence was found for the effect of CSF t-tau on the risk for LOAD (IVW OR, 1.15 for LOAD per 1 SD increase in the genetically predicted CSF t-tau; 95% CI, 0.85-1.45; P = 0.29) ( Table 1, Fig. 1E, Fig. 1F, Fig. 2E, and Fig. 2F ). There was no outlier detected by MR-PRESSO among the instruments of CSF t-tau. We confirmed that there was no evidence for horizontal pleiotropy (Intercept = -0.020, SE = 0.014, P = 0.18) and little heterogeneity between the IVs (Q = 18.45, P = 0.36, I 2 [%] = 8) ( Supplementary Table 4 ).
Given the observed ORs between the measured CSF biomarkers and the risk for LOAD, our MR analysis showed sufficient statistical power (> 90%) to detect the causal effects of the CSF biomarkers on the risk for LOAD with a level of significance of 0.05. Table 5 presents the estimates of the statistical power for our MR analysis.
Supplementary

Discussion
Using TSMR with genetic instruments from large-scale GWASs, we investigated the potential causal relationship between CSF biomarkers and the risk for LOAD. In this MR study, the genetic association of the CSF Aβ and p-tau instruments supported the causality of CSF Aβ and p-tau on the risk for LOAD. In contrast, we found no significant evidence of a causal relationship between CSF t-tau and the risk for LOAD. Our results are consistent with those of recent reports [41] [42] [43] .
Although Aβ, p-tau, and t-tau in the CSF have been reported to be useful as disease progression markers 41, 44 , there is still little evidence for their causal relationship with LOAD in randomized clinical trials (RCTs) 45, 46 . Recent RCTs on the elimination of the accumulated Aβ or tau proteins could not provide solid evidence for improvement of the symptoms of LOAD [47] [48] [49] . While clinical trials with small sample sizes have shown that eliminating the Aβ elements led to symptomatic improvement 50 , larger studies have failed to establish consistent results 47, 51, 52 . The agents reducing tau phosphorylation represented promising benefits in pilot clinical studies 53, 54 , but failed to show significant improvements in a cohort study 54 ; tau aggregation inhibitors showed a similar pattern 55 . Although another approach for proving the causality for LOAD is the induced pathologic accumulation of Aβ and tau proteins in RCTs, such intervention in humans is not allowed due to ethical issues. Instead, the development of AD phenotypes has been attempted in numerous animal models with accumulating Aβ 56, 57 and tau proteins 58 , and these still have various limitations. Transgenic animal models generally represent familiar AD rather than sporadic LOAD due to targeting a specific pathologic substance; therefore, they cannot provide a full explanation of LOAD 59 . In addition, animal models could not represent the complex symptomatology of dementia that presents in humans.
In consideration of these perspectives, the principles of MR can be applied to provide clues for the causality of these biomarkers in the etiology of LOAD 60 . This approach, which is conceptually similar to that of RCTs, 61 is based on the Mendel's law of segregation that genetic variants are randomly allocated at meiosis and that these genetic variants are consequently independent of many confounding factors or reverse causation. Thus, an MR analysis could enable the inference of the risk for LOAD driven through the genetically determined risk of amyloid accumulation and tau pathology. In our study, we found evidence supporting the potential causal relationships between Aβ and p-tau proteins in the CSF and the risk for LOAD using MR with genetic instruments selected from large-scale GWASs.
The causal estimates in our analysis were based on the largest GWAS to date, which may increase the precision of the estimates. We estimated a 0.63-fold decrease of the risk for LOAD per 1 SD increase in the CSF Aβ, and a 2.37-fold increase in the risk for LOAD per 1 SD increase in the CSF p-tau. These directions of association are consistent with those in previous reports 41, 62 . Markedly increased levels of p-tau proteins and decreased levels of Aβ in the CSF are represented as a specific finding in LOAD 41 . Aβ accumulation in the neuronal plaques and its binding to various receptors have been known as a hallmark of LOAD. Aβ binding to receptors has been understood as a process leading to neuronal toxicity, inducing mitochondrial dysfunction and oxidative stress 63, 64 T-tau in the CSF and the risk for LOAD did not show a causal relationship, which is consistent with the findings of previous studies 66, 67 . While the CSF level of p-tau increases specifically in LOAD, the CSF level of t-tau can increase in various conditions of neurodegeneration, including LOAD and other brain disorders 68 . Our result may support a recent proposal emphasizing the tau hyperphosphorylation in AD versus the excessive production of tau proteins 42 .
The measured CSF biomarkers in AD reflect both the production and the clearance of these markers at a given time. In contrast, neuroimages represent the neuropathologic load or damage accumulated over time directly in the brain 69 . Thus, imaging GWAS, such as amyloid or tau deposition in the brain measured by positron emission tomography (PET) 70 as phenotypes, could provide additional information for the association between these biomarkers and the risk for LOAD. However, the sample size of the current imaging genetic studies for these biomarkers is limited. Further studies with larger samples of genetic and imaging data could be helpful.
This study has several limitations. First, our causal estimates may be affected by several factors; horizontal pleiotropy, which was not detected by the applied MR sensitivity analysis methods 71 , and the possibility of misclassified LOAD cases 72, 73 . Unlike the balanced or positive bias induced by horizontal pleiotropy, the misclassified cases in the outcome may lead our results toward null. However, the estimates were statistically significant and consistent in various methods applied in our analysis. Second, our GWAS data included samples of Caucasian ancestry, which may limit the generalization of our findings. Finally, even though we employed the summary statistics from the largest GWASs on Aβ and tau proteins to date 21 , we applied a relaxed threshold to include more IVs as done in other psychiatric MR studies [24] [25] [26] [27] . Despite using instruments with a less stringent threshold, which may lead to null findings, our power analysis of the MR showed a statistical power greater than 90% and our analysis derived significant causal estimates.
In conclusion, this MR analysis suggested a possible causal relationship of the CSF Aβ and p-tau with the risk for LOAD. In addition, our findings showed that the association between t-tau and the risk for LOAD was not causal. Our results suggested that the etiology of LOAD involves multiple biological processes, including the amyloid and tau proteins in the AD pathophysiology. This complex nature of LOAD could partly explain the recent multiple failures of clinical trials of anti-amyloid monotherapy 47, 51, 52, 74, 75 . Further MR studies for multiple candidate biomarkers could be helpful to find appropriate drug targets for LOAD and larger GWAS data with sufficient numbers of IVs are necessary to validate the causality of CSF Aβ and p-tau on the risk for LOAD. : a Indicates odds for AD per 1 standard deviation increase in amyloid beta, phosphorylated tau, or total tau. b Top SNPs with P < 1×10 -5 were included in the analysis. c Indicates models without MR-PRESSO (Pleiotropy Residual Sum and Outlier). F. Forest plot of the estimate of total tau on the risk for Alzheimer's disease for each or all variants.
Figure legends
Figure 2.
Leave-one-out analyses and funnel plots for amyloid beta, phosphorylated tau, and total tau on the risk for late-onset Alzheimer's disease A. Leave-one-out analysis for amyloid beta on the risk for Alzheimer's disease.
B.
Funnel plot for amyloid beta on the risk for Alzheimer's disease.
C. Leave-one-out analysis for phosphorylated tau on the risk for Alzheimer's disease.
D.
Funnel plot for phosphorylated tau on the risk for Alzheimer's disease.
E. Leave-one-out analysis for total tau on the risk for Alzheimer's disease.
F. Funnel plot for total tau on the risk for Alzheimer's disease. 
